chr19-11421766-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_145045.5(ODAD3):​c.1501G>A​(p.Gly501Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00151 in 1,613,418 control chromosomes in the GnomAD database, including 40 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0085 ( 24 hom., cov: 32)
Exomes 𝑓: 0.00078 ( 16 hom. )

Consequence

ODAD3
NM_145045.5 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.00500

Publications

2 publications found
Variant links:
Genes affected
ODAD3 (HGNC:28303): (outer dynein arm docking complex subunit 3) This gene encodes a protein containing coiled-coil domains. The encoded protein functions in outer dynein arm assembly and is required for motile cilia function. Mutations in this gene result in primary ciliary dyskinesia. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2014]
ODAD3 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 30
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003677994).
BP6
Variant 19-11421766-C-T is Benign according to our data. Variant chr19-11421766-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 414140.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00847 (1290/152368) while in subpopulation AFR AF = 0.0292 (1216/41592). AF 95% confidence interval is 0.0279. There are 24 homozygotes in GnomAd4. There are 606 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 24 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ODAD3NM_145045.5 linkc.1501G>A p.Gly501Ser missense_variant Exon 11 of 13 ENST00000356392.9 NP_659482.3 A5D8V7-1B3KPH7
ODAD3NM_001302453.1 linkc.1339G>A p.Gly447Ser missense_variant Exon 11 of 13 NP_001289382.1 A5D8V7-2
ODAD3NM_001302454.2 linkc.1321G>A p.Gly441Ser missense_variant Exon 9 of 11 NP_001289383.1 K7EN59

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ODAD3ENST00000356392.9 linkc.1501G>A p.Gly501Ser missense_variant Exon 11 of 13 1 NM_145045.5 ENSP00000348757.3 A5D8V7-1

Frequencies

GnomAD3 genomes
AF:
0.00847
AC:
1289
AN:
152250
Hom.:
23
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0293
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00367
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.00478
GnomAD2 exomes
AF:
0.00194
AC:
484
AN:
248870
AF XY:
0.00149
show subpopulations
Gnomad AFR exome
AF:
0.0286
Gnomad AMR exome
AF:
0.000811
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000621
Gnomad OTH exome
AF:
0.000661
GnomAD4 exome
AF:
0.000784
AC:
1146
AN:
1461050
Hom.:
16
Cov.:
31
AF XY:
0.000700
AC XY:
509
AN XY:
726820
show subpopulations
African (AFR)
AF:
0.0285
AC:
953
AN:
33480
American (AMR)
AF:
0.00107
AC:
48
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000812
AC:
7
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52642
Middle Eastern (MID)
AF:
0.000867
AC:
5
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000117
AC:
13
AN:
1111966
Other (OTH)
AF:
0.00199
AC:
120
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
70
140
209
279
349
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00847
AC:
1290
AN:
152368
Hom.:
24
Cov.:
32
AF XY:
0.00813
AC XY:
606
AN XY:
74500
show subpopulations
African (AFR)
AF:
0.0292
AC:
1216
AN:
41592
American (AMR)
AF:
0.00366
AC:
56
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000103
AC:
7
AN:
68038
Other (OTH)
AF:
0.00473
AC:
10
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
63
126
188
251
314
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00440
Hom.:
9
Bravo
AF:
0.00938
ESP6500AA
AF:
0.0274
AC:
108
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00246
AC:
297
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000119

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Primary ciliary dyskinesia 30 Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 30, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Aug 11, 2023
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

See Variant Classification Assertion Criteria. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.63
T
BayesDel_noAF
Benign
-0.65
CADD
Benign
11
DANN
Benign
0.97
DEOGEN2
Benign
0.0037
T;T;.
Eigen
Benign
-0.43
Eigen_PC
Benign
-0.37
FATHMM_MKL
Benign
0.22
N
LIST_S2
Benign
0.68
T;T;T
MetaRNN
Benign
0.0037
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.7
L;.;.
PhyloP100
0.0050
PrimateAI
Benign
0.30
T
PROVEAN
Benign
-0.12
N;.;.
REVEL
Benign
0.031
Sift
Benign
0.63
T;.;.
Sift4G
Benign
0.82
T;T;T
Polyphen
0.33
B;.;.
Vest4
0.16
MVP
0.44
MPC
0.46
ClinPred
0.010
T
GERP RS
3.9
Varity_R
0.11
gMVP
0.14
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs77133587; hg19: chr19-11532434; API